Detalhe da pesquisa
1.
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma.
BMC Cancer
; 20(1): 612, 2020 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32605647